-
BIB Dashboard
- Holdings
ProShares Ultra Nasdaq Biotechnology
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
U.S. Treasury Bills | 10.00 mm | 10.00 mm principal | 12.90 | Short-term investment vehicle | Long | USA |
GILD Gilead Sciences, Inc. | 5.42 mm | 58.53 k shares | 6.99 | Common equity | Long | USA |
Repurchase Agreement | 5.09 mm | 5.09 mm principal | 6.56 | Repurchase agreement | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 4.37 mm | 9.33 k shares | 5.63 | Common equity | Long | USA |
AMGN Amgen Inc. | 3.92 mm | 13.85 k shares | 5.06 | Common equity | Long | USA |
Repurchase Agreement | 3.84 mm | 3.84 mm principal | 4.96 | Repurchase agreement | Long | USA |
Repurchase Agreement | 3.63 mm | 3.63 mm principal | 4.69 | Repurchase agreement | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 2.93 mm | 3.90 k shares | 3.78 | Common equity | Long | USA |
AstraZeneca plc
|
2.21 mm | 32.65 k shares | 2.85 | Common equity | Long | UK |
ALNY Alnylam Pharmaceuticals, Inc. | 1.82 mm | 7.20 k shares | 2.35 | Common equity | Long | USA |
Total Return Swap
BNP Paribas SA
|
1.47 mm | 6.87 k contracts | 1.90 | Equity derivative | N/A | USA |
Repurchase Agreement | 1.45 mm | 1.45 mm principal | 1.88 | Repurchase agreement | Long | USA |
BIIB Biogen Inc. | 1.31 mm | 8.16 k shares | 1.69 | Common equity | Long | USA |
ILMN Illumina, Inc. | 1.29 mm | 8.93 k shares | 1.66 | Common equity | Long | USA |
ARGX argenx SE | 1.11 mm | 1.80 k shares | 1.43 | Common equity | Long | Netherlands |
MRNA Moderna, Inc. | 927.94 k | 21.55 k shares | 1.20 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 924.00 k | 2.49 k shares | 1.19 | Common equity | Long | USA |
VTRS Viatris Inc. | 875.85 k | 66.91 k shares | 1.13 | Common equity | Long | USA |
INCY Incyte Corporation | 805.27 k | 10.80 k shares | 1.04 | Common equity | Long | USA |
SNY Sanofi | 794.75 k | 16.39 k shares | 1.03 | Common equity | Long | France |
SMMT Summit Therapeutics Inc. | 749.73 k | 40.61 k shares | 0.97 | Common equity | Long | USA |
Repurchase Agreement | 726.56 k | 726.56 k principal | 0.94 | Repurchase agreement | Long | USA |
INSM Insmed Incorporated | 724.09 k | 9.63 k shares | 0.93 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 717.53 k | 5.66 k shares | 0.93 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 712.97 k | 5.35 k shares | 0.92 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 704.80 k | 10.67 k shares | 0.91 | Common equity | Long | USA |
Royalty Pharma plc, Class A
|
669.67 k | 25.12 k shares | 0.86 | Common equity | Long | UK |
BNTX BioNTech SE | 650.67 k | 5.50 k shares | 0.84 | Common equity | Long | Germany |
MEDP Medpace Holdings, Inc. | 592.70 k | 1.74 k shares | 0.76 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 590.38 k | 6.26 k shares | 0.76 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 583.14 k | 15.99 k shares | 0.75 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 541.77 k | 9.37 k shares | 0.70 | Common equity | Long | USA |
ONC BeiGene, Ltd. | 532.34 k | 2.48 k shares | 0.69 | Common equity | Long | Cayman Islands |
Roivant Sciences Ltd.
|
526.89 k | 41.46 k shares | 0.68 | Common equity | Long | Bermuda |
ITCI Intra-Cellular Therapies, Inc. | 507.22 k | 5.92 k shares | 0.65 | Common equity | Long | USA |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | 456.35 k | 456.35 k shares | 0.59 | Short-term investment vehicle | Long | USA |
ASND Ascendis Pharma A/S | 441.99 k | 3.25 k shares | 0.57 | Common equity | Long | Denmark |
Jazz Pharmaceuticals plc
|
420.94 k | 3.46 k shares | 0.54 | Common equity | Long | Ireland |
Madrigal Pharmaceuticals, Inc. | 398.09 k | 1.21 k shares | 0.51 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 342.44 k | 3.55 k shares | 0.44 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 342.27 k | 7.10 k shares | 0.44 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 342.02 k | 6.60 k shares | 0.44 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 321.56 k | 3.33 k shares | 0.41 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 317.65 k | 1.61 k shares | 0.41 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 292.88 k | 8.20 k shares | 0.38 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 285.56 k | 10.54 k shares | 0.37 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 282.49 k | 6.57 k shares | 0.36 | Common equity | Long | USA |
Alkermes plc
|
267.94 k | 9.23 k shares | 0.35 | Common equity | Long | Ireland |
ACLX Arcellx, Inc. | 265.53 k | 3.02 k shares | 0.34 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 264.31 k | 2.69 k shares | 0.34 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 262.78 k | 13.07 k shares | 0.34 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 256.60 k | 4.49 k shares | 0.33 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 246.10 k | 5.17 k shares | 0.32 | Common equity | Long | USA |
GH Guardant Health, Inc. | 245.42 k | 6.89 k shares | 0.32 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
244.23 k | 4.77 k shares | 0.32 | Common equity | Long | Switzerland |
APLS Apellis Pharmaceuticals, Inc. | 231.64 k | 6.83 k shares | 0.30 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 231.44 k | 8.21 k shares | 0.30 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 212.55 k | 3.43 k shares | 0.27 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 200.68 k | 8.03 k shares | 0.26 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 196.81 k | 39.05 k shares | 0.25 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 192.60 k | 4.58 k shares | 0.25 | Common equity | Long | Cayman Islands |
AGIO Agios Pharmaceuticals, Inc. | 189.45 k | 3.19 k shares | 0.24 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 189.21 k | 4.31 k shares | 0.24 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 184.90 k | 4.31 k shares | 0.24 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 181.48 k | 6.97 k shares | 0.23 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 181.13 k | 4.25 k shares | 0.23 | Common equity | Long | Canada |
SRRK Scholar Rock Holding Corporation | 178.99 k | 4.49 k shares | 0.23 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 173.48 k | 5.26 k shares | 0.22 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 172.76 k | 4.17 k shares | 0.22 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 172.40 k | 5.63 k shares | 0.22 | Common equity | Long | USA |
Merus NV
|
171.51 k | 3.83 k shares | 0.22 | Common equity | Long | Netherlands |
KYMR Kymera Therapeutics, Inc. | 169.64 k | 3.62 k shares | 0.22 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 165.89 k | 16.62 k shares | 0.21 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 161.65 k | 3.29 k shares | 0.21 | Common equity | Long | USA |
VRNA Verona Pharma plc | 160.34 k | 4.05 k shares | 0.21 | Common equity | Long | UK |
VCEL Vericel Corporation | 159.48 k | 2.74 k shares | 0.21 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 158.58 k | 17.02 k shares | 0.20 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 152.93 k | 3.07 k shares | 0.20 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 151.76 k | 9.30 k shares | 0.20 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 144.63 k | 3.30 k shares | 0.19 | Common equity | Long | USA |
GERN Geron Corporation | 139.22 k | 33.79 k shares | 0.18 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 132.28 k | 2.93 k shares | 0.17 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 129.44 k | 4.73 k shares | 0.17 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 126.50 k | 4.62 k shares | 0.16 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 125.00 k | 3.89 k shares | 0.16 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 124.39 k | 1.02 k shares | 0.16 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 124.26 k | 17.58 k shares | 0.16 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 123.50 k | 2.67 k shares | 0.16 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 123.41 k | 2.73 k shares | 0.16 | Common equity | Long | USA |
Novocure Ltd.
|
121.60 k | 6.07 k shares | 0.16 | Common equity | Long | Jersey |
KROS Keros Therapeutics, Inc. | 121.48 k | 2.10 k shares | 0.16 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 113.96 k | 2.52 k shares | 0.15 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 113.00 k | 3.09 k shares | 0.15 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 111.82 k | 2.13 k shares | 0.14 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 110.72 k | 3.34 k shares | 0.14 | Common equity | Long | Cayman Islands |
HRMY Harmony Biosciences Holdings, Inc. | 110.49 k | 3.19 k shares | 0.14 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 105.90 k | 1.67 k shares | 0.14 | Common equity | Long | USA |
FTRE Fortrea Holdings Inc. | 105.71 k | 5.02 k shares | 0.14 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
105.52 k | 6.99 k shares | 0.14 | Common equity | Long | Singapore |
MNKD MannKind Corporation | 104.53 k | 15.42 k shares | 0.13 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 102.79 k | 3.85 k shares | 0.13 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 94.43 k | 7.34 k shares | 0.12 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 88.97 k | 5.70 k shares | 0.11 | Common equity | Long | USA |
XNCR Xencor, Inc. | 88.76 k | 3.47 k shares | 0.11 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 86.97 k | 11.60 k shares | 0.11 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 86.45 k | 8.74 k shares | 0.11 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 85.45 k | 6.55 k shares | 0.11 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 83.32 k | 1.99 k shares | 0.11 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 82.86 k | 5.09 k shares | 0.11 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 80.60 k | 4.29 k shares | 0.10 | Common equity | Long | USA |
Zai Lab Ltd.
|
80.38 k | 2.79 k shares | 0.10 | Common equity | Long | Cayman Islands |
NRIX Nurix Therapeutics, Inc. | 79.82 k | 3.61 k shares | 0.10 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 79.74 k | 4.77 k shares | 0.10 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 78.88 k | 5.44 k shares | 0.10 | Common equity | Long | USA |
NVAX Novavax, Inc. | 78.23 k | 8.97 k shares | 0.10 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 77.97 k | 5.60 k shares | 0.10 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 74.85 k | 13.20 k shares | 0.10 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 73.42 k | 5.10 k shares | 0.09 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc. | 71.02 k | 8.02 k shares | 0.09 | Common equity | Long | Canada |
CNTA Centessa Pharmaceuticals plc | 70.98 k | 3.96 k shares | 0.09 | Common equity | Long | UK |
IMCR Immunocore Holdings plc | 70.91 k | 2.17 k shares | 0.09 | Common equity | Long | UK |
ANIP ANI Pharmaceuticals, Inc. | 67.53 k | 1.18 k shares | 0.09 | Common equity | Long | USA |
INVA Innoviva, Inc. | 66.62 k | 3.51 k shares | 0.09 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 64.56 k | 2.65 k shares | 0.08 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 60.97 k | 7.66 k shares | 0.08 | Common equity | Long | USA |
Avadel Pharmaceuticals plc
|
59.68 k | 5.40 k shares | 0.08 | Common equity | Long | Ireland |
COGT Cogent Biosciences, Inc. | 58.35 k | 6.14 k shares | 0.08 | Common equity | Long | USA |
Zymeworks Inc. | 56.13 k | 3.98 k shares | 0.07 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 55.08 k | 1.81 k shares | 0.07 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 53.87 k | 3.83 k shares | 0.07 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 53.37 k | 5.94 k shares | 0.07 | Common equity | Long | USA |
Genmab A/S
|
50.57 k | 2.35 k shares | 0.07 | Common equity | Long | Denmark |
Kiniksa Pharmaceuticals International plc, Class A
|
50.28 k | 2.28 k shares | 0.06 | Common equity | Long | UK |
ABCL AbCellera Biologics Inc. | 49.72 k | 16.52 k shares | 0.06 | Common equity | Long | Canada |
ADPT Adaptive Biotechnologies Corporation | 49.11 k | 8.27 k shares | 0.06 | Common equity | Long | USA |
Prothena Corp. plc
|
48.89 k | 3.02 k shares | 0.06 | Common equity | Long | Ireland |
EOLS Evolus, Inc. | 48.42 k | 3.54 k shares | 0.06 | Common equity | Long | USA |
GRFS Grifols, S.A. | 47.80 k | 6.84 k shares | 0.06 | Common equity | Long | Spain |
KURA Kura Oncology, Inc. | 47.41 k | 4.29 k shares | 0.06 | Common equity | Long | USA |
CSTL Castle Biosciences, Inc. | 47.12 k | 1.56 k shares | 0.06 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 47.04 k | 3.41 k shares | 0.06 | Common equity | Long | USA |
ERAS Erasca, Inc. | 45.28 k | 15.83 k shares | 0.06 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings, Inc. | 45.01 k | 7.94 k shares | 0.06 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 44.97 k | 4.75 k shares | 0.06 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 43.73 k | 3.25 k shares | 0.06 | Common equity | Long | USA |
PCRX Pacira BioSciences, Inc. | 43.71 k | 2.59 k shares | 0.06 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 42.45 k | 2.08 k shares | 0.05 | Common equity | Long | UK |
ANAB AnaptysBio, Inc. | 42.23 k | 1.69 k shares | 0.05 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 39.14 k | 3.95 k shares | 0.05 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 37.42 k | 1.44 k shares | 0.05 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 37.23 k | 11.49 k shares | 0.05 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 37.16 k | 11.19 k shares | 0.05 | Common equity | Long | UK |
ABUS Arbutus Biopharma Corporation | 36.62 k | 10.59 k shares | 0.05 | Common equity | Long | Canada |
CureVac NV
|
36.08 k | 12.57 k shares | 0.05 | Common equity | Long | Netherlands |
MLYS Mineralys Therapeutics, Inc. | 35.59 k | 2.79 k shares | 0.05 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 35.28 k | 7.51 k shares | 0.05 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 34.67 k | 12.47 k shares | 0.04 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 33.97 k | 3.83 k shares | 0.04 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 32.49 k | 3.21 k shares | 0.04 | Common equity | Long | USA |
Total Return Swap
Societe Generale
|
31.87 k | 1.04 k contracts | 0.04 | Equity derivative | N/A | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 31.53 k | 8.96 k shares | 0.04 | Common equity | Long | USA |
Galapagos NV
|
31.37 k | 1.14 k shares | 0.04 | Common equity | Long | Belgium |
SVRA Savara Inc. | 31.01 k | 9.23 k shares | 0.04 | Common equity | Long | USA |
GRAL GRAIL, Inc. | 30.47 k | 1.74 k shares | 0.04 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 30.24 k | 6.69 k shares | 0.04 | Common equity | Long | USA |
UroGen Pharma Ltd.
|
29.97 k | 2.36 k shares | 0.04 | Common equity | Long | Israel |
YMAB Y-mAbs Therapeutics, Inc. | 29.76 k | 2.50 k shares | 0.04 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 29.51 k | 1.74 k shares | 0.04 | Common equity | Long | Cayman Islands |
MeiraGTx Holdings plc
|
29.38 k | 4.34 k shares | 0.04 | Common equity | Long | Cayman Islands |
THRD Third Harmonic Bio, Inc. | 29.37 k | 2.30 k shares | 0.04 | Common equity | Long | USA |
NxStage Medical, Inc. | 29.17 k | 15.27 k shares | 0.04 | Common equity | Long | USA |
SIGA SIGA Technologies, Inc. | 29.13 k | 4.00 k shares | 0.04 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 29.08 k | 11.72 k shares | 0.04 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 27.79 k | 1.52 k shares | 0.04 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 27.48 k | 2.77 k shares | 0.04 | Common equity | Long | USA |
Xeris Pharmaceuticals Inc | 27.39 k | 8.35 k shares | 0.04 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 27.34 k | 3.09 k shares | 0.04 | Common equity | Long | USA |
PAHC Phibro Animal Health Corporation | 26.62 k | 1.14 k shares | 0.03 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 26.61 k | 4.74 k shares | 0.03 | Common equity | Long | USA |
OABI OmniAb, Inc. | 25.88 k | 6.62 k shares | 0.03 | Common equity | Long | USA |
SLRN Acelyrin, Inc. | 25.46 k | 5.60 k shares | 0.03 | Common equity | Long | USA |
Theravance Biopharma, Inc.
|
25.38 k | 2.74 k shares | 0.03 | Common equity | Long | Cayman Islands |
TERN Terns Pharmaceuticals, Inc. | 24.61 k | 3.94 k shares | 0.03 | Common equity | Long | USA |
Total Return Swap
Morgan Stanley & Co. International plc
|
24.56 k | 683.00 contracts | 0.03 | Equity derivative | N/A | USA |
KALV KalVista Pharmaceuticals, Inc. | 24.29 k | 2.42 k shares | 0.03 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 23.67 k | 6.01 k shares | 0.03 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 22.85 k | 2.91 k shares | 0.03 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 22.14 k | 6.73 k shares | 0.03 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 21.22 k | 5.88 k shares | 0.03 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 21.15 k | 3.82 k shares | 0.03 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 20.96 k | 3.06 k shares | 0.03 | Common equity | Long | USA |
MXCT MaxCyte, Inc. | 20.92 k | 5.89 k shares | 0.03 | Common equity | Long | USA |
AC Immune SA
|
18.83 k | 5.54 k shares | 0.02 | Common equity | Long | Switzerland |
SAGE Sage Therapeutics, Inc. | 18.72 k | 3.42 k shares | 0.02 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 17.51 k | 2.05 k shares | 0.02 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc. | 16.83 k | 3.27 k shares | 0.02 | Common equity | Long | USA |
ATAI Life Sciences NV
|
16.75 k | 9.41 k shares | 0.02 | Common equity | Long | Netherlands |
uniQure NV
|
16.31 k | 2.73 k shares | 0.02 | Common equity | Long | Netherlands |
LXRX Lexicon Pharmaceuticals, Inc. | 16.29 k | 20.26 k shares | 0.02 | Common equity | Long | USA |
ACRS Aclaris Therapeutics, Inc. | 16.28 k | 4.00 k shares | 0.02 | Common equity | Long | USA |